PAPER Neale JH, Olszewski RT, Gehl LM, Wroblewska B, Bzdega T

The neurotransmitter N-acetylaspartylglutamate in models of pain, ALS, diabetic neuropathy, CNS injury and schizophrenia.

Trends Pharmacol Sci. 2005 Sep;26(9):477-84. PubMed.

PAPER Waetzig V, Herdegen T

Context-specific inhibition of JNKs: overcoming the dilemma of protection and damage.

Trends Pharmacol Sci. 2005 Sep;26(9):455-61. PubMed.

PAPER Marchetti B, Abbracchio MP

To be or not to be (inflamed)--is that the question in anti-inflammatory drug therapy of neurodegenerative disorders?

Trends Pharmacol Sci. 2005 Oct;26(10):517-25. PubMed.

PAPER Beglopoulos V, Shen J

Regulation of CRE-dependent transcription by presenilins: prospects for therapy of Alzheimer's disease.

Trends Pharmacol Sci. 2006 Jan;27(1):33-40. PubMed.

PAPER Hefti FF, Rosenthal A, Walicke PA, Wyatt S, Vergara G, Shelton DL, Davies AM

Novel class of pain drugs based on antagonism of NGF.

Trends Pharmacol Sci. 2006 Feb;27(2):85-91. PubMed.

PAPER Lee CM, Farde L

Using positron emission tomography to facilitate CNS drug development.

Trends Pharmacol Sci. 2006 Jun;27(6):310-6. PubMed.

PAPER Papadopoulos V, Baraldi M, Guilarte TR, Knudsen TB, Lacapère JJ, Lindemann P, Norenberg MD, Nutt D, Weizman A, Zhang MR, Gavish M

Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function.

Trends Pharmacol Sci. 2006 Aug;27(8):402-9. PubMed.

PAPER Gotti C, Zoli M, Clementi F

Brain nicotinic acetylcholine receptors: native subtypes and their relevance.

Trends Pharmacol Sci. 2006 Sep;27(9):482-91. PubMed.

PAPER Zhang HY, Tang XC

Neuroprotective effects of huperzine A: new therapeutic targets for neurodegenerative disease.

Trends Pharmacol Sci. 2006 Dec;27(12):619-25. PubMed.

PAPER Alkon DL, Sun MK, Nelson TJ

PKC signaling deficits: a mechanistic hypothesis for the origins of Alzheimer's disease.

Trends Pharmacol Sci. 2007 Feb;28(2):51-60. PubMed.

PAPER Bespalov MM, Saarma M

GDNF family receptor complexes are emerging drug targets.

Trends Pharmacol Sci. 2007 Feb;28(2):68-74. PubMed.

PAPER Centonze D, Finazzi-Agrò A, Bernardi G, Maccarrone M

The endocannabinoid system in targeting inflammatory neurodegenerative diseases.

Trends Pharmacol Sci. 2007 Apr;28(4):180-7. PubMed.

PAPER Culman J, Zhao Y, Gohlke P, Herdegen T

PPAR-gamma: therapeutic target for ischemic stroke.

Trends Pharmacol Sci. 2007 May;28(5):244-9. PubMed.

PAPER Zipp F, Waiczies S, Aktas O, Neuhaus O, Hemmer B, Schraven B, Nitsch R, Hartung HP

Impact of HMG-CoA reductase inhibition on brain pathology.

Trends Pharmacol Sci. 2007 Jul;28(7):342-9. PubMed.

PAPER Weggen S, Rogers M, Eriksen J

NSAIDs: small molecules for prevention of Alzheimer's disease or precursors for future drug development?

Trends Pharmacol Sci. 2007 Oct;28(10):536-43. PubMed.